An efficient strategy for the synthesis of (T-5')adenylate trimer conjugates with 2'-terminal 3'-0-(w-hydroxyalkyl) and 3'-0-(w-carboxyalkyl) spacers is reported. Npeoc-protected adenosine building blocks 37-40 for Whereas the levulinoyl (lev) and 9H-fluoren-9-ylmethyl (fm) blocking groups could be cleaved off selectively from the trimers 42, 43, and 48 yielding the intermediates 44, 45, and 49 for the synthesis of the 3'-0-(w-hydroxyalkyl)trimers 53, 54 and the cholesterol conjugates 59-61, the 2-cyanoethyl (ce) protecting group of 47, however, could not be removed in a similar manner from the carboxy function. Trimer 47 served as precursor for the preparation of the trimer 55 with a terminal 3'-0-(5-~arboxypentyI)adenosine moiety. The metabolically stable 3'-0-alkyl-(2'-5')A derivatives were tested regarding inhibition of HIV-1 syncytia formation and HIV-1 RT activity. Only the conjugate 59 showed significant effects, whereas the trimers 53-55 and the conjugates 60 and 61 were less potent inhibitors, even at 100-fold larger concentrations.